The publication of the renewed Women’s Health Strategy for England marks a clear attempt to reposition women’s health within the Government’s wider programme of NHS reform. Ministers have framed this as an opportunity to go further and faster than the original Strategy, building on its foundations while addressing longstanding gaps in delivery. It has been well received by stakeholders across the ecosystem, with many welcoming the recognition of persistently poor experiences of care.
Overall, the renewed Strategy is broader in scope and more explicitly aligned with the NHS reform agenda. It emphasises prevention, digital transformation, community-based care and patient voice, reflecting a wider shift in the operating model.
However, comparison with the previous Strategy suggests a more nuanced picture. While the direction of travel is arguably more ambitious, there are notable differences in how that ambition is expressed – particularly in relation to tangibility, funding, and delivery mechanisms.
Different approaches to delivery
A central feature of the 2022 Strategy was its focus on specific interventions designed to improve access to services. Women’s Health Hubs were positioned as a core delivery model, supported by £25 million in ringfenced funding and a mandate for every ICB to set up a hub. This provided a visible signal of intent and directly linked policy ambition to resource allocation. It created a tangible model that could be implemented, scaled, and evaluated across the system.
The renewed Strategy adopts a different approach and situates women’s health within a broader set of structural reforms, including the development of neighbourhood health services, expansion of digital pathways, and changes to accountability mechanisms. Whilst there are welcome commitments on prioritising funding for specialist women’s health services, the details on how this will be achieved remain light-touch.
The approach has shifted from intervention-based policy to system-based reform. While this may offer greater long-term flexibility, it also makes the route to delivery less explicit. The accompanying funding commitments are either non-specific to women’s health or relatively small in scale.
The renewed Strategy is therefore clearer on how the system should evolve, but less specific on the mechanisms through which women’s access to services will improve in the medium term.
National direction and local delivery
The original Strategy provided a stronger sense of national direction, with clear expectations around priority areas and delivery models.
By contrast, the renewed Strategy places greater emphasis on local flexibility, with Integrated Care Boards (ICBs) responsible for commissioning and designing services in line with local need. This approach is consistent with wider reforms aimed at decentralisation and system autonomy.
However, this shift also risks creating greater variation in implementation. Without clearly defined national expectations or mandated service models, the pace and extent of progress may differ significantly between areas. This reflects a broader trade-off between consistency and flexibility, with the renewed Strategy leaning more heavily towards the latter.
Notably, the Strategy introduces “patient power payments”, linking a proportion of provider funding to patient-reported experience. Where care is judged to fall short, funding may be withheld based on feedback. However, it specifies that any funding withheld would be reinvested into improving the same service, meaning this functions more as a reallocation mechanism than a financial penalty.
Complexity and scope
The renewed Strategy is more expansive than its predecessor. It extends beyond healthcare services to address a wider set of determinants, including workforce participation, economic inactivity, prevention, and research and innovation. This broader scope reflects a more comprehensive view of the factors shaping women’s health outcomes and aligns with cross-government priorities.
At the same time, the increased scope introduces greater complexity. The Strategy is embedded within a wider reform agenda that encompasses multiple policy areas, delivery partners, and timelines. This may make it more challenging to isolate specific actions, track progress, and attribute impact.
Health inequalities
The 2022 Strategy acknowledged variation in access and outcomes, but this was not a central organising principle. The renewed Strategy, by contrast, embeds addressing inequalities throughout, highlighting disparities linked to deprivation, ethnicity and geography, and positioning their reduction as a core objective.
However, the mechanisms for addressing these inequalities rely heavily on local delivery. ICBs are expected to identify and respond to variation, supported by improved data and performance metrics. While this approach allows for flexibility and tailoring to local populations, it also introduces uncertainty around consistency. Without clearly defined national interventions, progress may vary between areas.
Conclusion
Ultimately, the Renewed Strategy indicates a shift in approach rather than a clear step forward in delivery. The original Strategy established visibility and introduced tangible mechanisms to begin driving change, while the refresh sets out a broader, more systemic vision for the future.
The risk is not a lack of ambition, but a loss of clarity around how that ambition translates into real-world improvements for women. Success will depend on whether these system-level reforms can deliver meaningful, consistent change in access, experience and outcomes across the country.
